In-vitro Dissolution complementary to BE [Regulatives / Guidelines]

posted by sireen – Jordan, 2013-12-14 13:27 (4570 d 10:08 ago) – Posting: # 12059
Views: 12,612

Dear members,

Probably this is an old issue for most of you... The EMEA guideline on the investigation of BE states that "Similarity of in vitro dissolution should be demonstrated at all conditions within the applied product series, i.e. between additional strengths and the strength(s) (i.e. batch(es)) used for bioequivalence testing."... What about the QC dissolution method.... what I mean to ask is: would an in-vitro dissolution in SGF media, reflect bioequivalency if the three different buffers (pH 1.2, 4.5 and 6.8) demonstrated otherwise.

Also, some lectures state to conduct in-vitro dissolution profiles under similar conditions... does that mean within a certain period of time... can't I compare my current data against results from 2 years ago... Would that raise questions by regulatory authorities.

Apologies if such questions are depressingly not challenging for you, nevertheless, thank you for your comments...

Sireen

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
147 visitors (0 registered, 147 guests [including 11 identified bots]).
Forum time: 00:36 CEST (Europe/Vienna)

Actually, science starts to become interesting
only where it ends.    Justus von Liebig

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5